<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23800014</PMID><DateCompleted><Year>2014</Year><Month>02</Month><Day>13</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1423-0127</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>1</Issue><PubDate><Year>2013</Year><Month>Jun</Month><Day>25</Day></PubDate></JournalIssue><Title>Journal of biomedical science</Title><ISOAbbreviation>J Biomed Sci</ISOAbbreviation></Journal><ArticleTitle>An emerging role for the anti-inflammatory cytokine interleukin-10 in dengue virus infection.</ArticleTitle><Pagination><StartPage>40</StartPage><MedlinePgn>40</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/1423-0127-20-40</ELocationID><Abstract><AbstractText>Infection with dengue virus (DENV) causes both mild dengue fever and severe dengue diseases, such as dengue hemorrhagic fever and dengue shock syndrome. The pathogenic mechanisms for DENV are complicated, involving viral cytotoxicity, immunopathogenesis, autoimmunity, and underlying host diseases. Viral load correlates with disease severity, while the antibody-dependent enhancement of infection largely determines the secondary effects of DENV infection. Epidemiological and experimental studies have revealed an association between the plasma levels of interleukin (IL)-10, which is the master anti-inflammatory cytokine, and disease severity in patients with DENV infection. Based on current knowledge of IL-10-mediated immune regulation during infection, researchers speculate an emerging role for IL-10 in clinical disease prognosis and dengue pathogenesis. However, the regulation of dengue pathogenesis has not been fully elucidated. This review article discusses the regulation and implications of IL-10 in DENV infection. For future strategies against DENV infection, manipulating IL-10 may be an effective antiviral treatment in addition to the development of a safe dengue vaccine.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Tsung-Ting</ForeName><Initials>TT</Initials><AffiliationInfo><Affiliation>Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chuang</LastName><ForeName>Yi-Jui</ForeName><Initials>YJ</Initials></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Yee-Shin</ForeName><Initials>YS</Initials></Author><Author ValidYN="Y"><LastName>Wan</LastName><ForeName>Shu-Wen</ForeName><Initials>SW</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Chia-Ling</ForeName><Initials>CL</Initials></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Chiou-Feng</ForeName><Initials>CF</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>06</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Biomed Sci</MedlineTA><NlmUniqueID>9421567</NlmUniqueID><ISSNLinking>1021-7770</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000893">Anti-Inflammatory Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>130068-27-8</RegistryNumber><NameOfSubstance UI="D016753">Interleukin-10</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000893" MajorTopicYN="N">Anti-Inflammatory Agents</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="N">Dengue</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016753" MajorTopicYN="N">Interleukin-10</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>3</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>6</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23800014</ArticleId><ArticleId IdType="pmc">PMC3700829</ArticleId><ArticleId IdType="doi">10.1186/1423-0127-20-40</ArticleId><ArticleId IdType="pii">1423-0127-20-40</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Diaz-Quijano FA. Dengue. N Engl J Med. 2012;367:180. author reply 181.</Citation><ArticleIdList><ArticleId IdType="pubmed">22784125</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander N, Balmaseda A, Coelho IC, Dimaano E, Hien TT, Hung NT, Janisch T, Kroeger A, Lum LC, Martinez E. et al.Multicentre prospective study on dengue classification in four South-east Asian and three Latin American countries. Trop med int health TM IH. 2011;16:936&#x2013;948. doi: 10.1111/j.1365-3156.2011.02793.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-3156.2011.02793.x</ArticleId><ArticleId IdType="pubmed">21624014</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubler DJ, Hunsperger E, Kroeger A, Margolis HS, Martinez E. et al.Dengue: a continuing global threat. Nat Rev Microbiol. 2010;8:S7&#x2013;S16. doi: 10.1038/nrmicro2460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro2460</ArticleId><ArticleId IdType="pmc">PMC4333201</ArticleId><ArticleId IdType="pubmed">21079655</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrison J, Aguirre S, Fernandez-Sesma A. Innate immunity evasion by Dengue virus. Viruses. 2012;4:397&#x2013;413. doi: 10.3390/v4030397.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v4030397</ArticleId><ArticleId IdType="pmc">PMC3347034</ArticleId><ArticleId IdType="pubmed">22590678</ArticleId></ArticleIdList></Reference><Reference><Citation>Perera R, Kuhn RJ. Structural proteomics of dengue virus. Curr Opin Microbiol. 2008;11:369&#x2013;377. doi: 10.1016/j.mib.2008.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mib.2008.06.004</ArticleId><ArticleId IdType="pmc">PMC2581888</ArticleId><ArticleId IdType="pubmed">18644250</ArticleId></ArticleIdList></Reference><Reference><Citation>Clyde K, Kyle JL, Harris E. Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis. J Virol. 2006;80:11418&#x2013;11431. doi: 10.1128/JVI.01257-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01257-06</ArticleId><ArticleId IdType="pmc">PMC1642597</ArticleId><ArticleId IdType="pubmed">16928749</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodenhuis-Zybert IA, Wilschut J, Smit JM. Dengue virus life cycle: viral and host factors modulating infectivity. Cell mol life sci CMLS. 2010;67:2773&#x2013;2786. doi: 10.1007/s00018-010-0357-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-010-0357-z</ArticleId><ArticleId IdType="pubmed">20372965</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Maguire T, Hileman RE, Fromm JR, Esko JD, Linhardt RJ, Marks RM. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nature med. 1997;3:866&#x2013;871. doi: 10.1038/nm0897-866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm0897-866</ArticleId><ArticleId IdType="pubmed">9256277</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YC, Wang SY, King CC. Bacterial lipopolysaccharide inhibits dengue virus infection of primary human monocytes/macrophages by blockade of virus entry via a CD14-dependent mechanism. J Virol. 1999;73:2650&#x2013;2657.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC104020</ArticleId><ArticleId IdType="pubmed">10074110</ArticleId></ArticleIdList></Reference><Reference><Citation>Tassaneetrithep B, Burgess TH, Granelli-Piperno A, Trumpfheller C, Finke J, Sun W, Eller MA, Pattanapanyasat K, Sarasombath S, Birx DL. et al.DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J exper med. 2003;197:823&#x2013;829. doi: 10.1084/jem.20021840.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20021840</ArticleId><ArticleId IdType="pmc">PMC2193896</ArticleId><ArticleId IdType="pubmed">12682107</ArticleId></ArticleIdList></Reference><Reference><Citation>Jindadamrongwech S, Thepparit C, Smith DR. Identification of GRP 78 (BiP) as a liver cell expressed receptor element for dengue virus serotype 2. Arch Virol. 2004;149:915&#x2013;927. doi: 10.1007/s00705-003-0263-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-003-0263-x</ArticleId><ArticleId IdType="pubmed">15098107</ArticleId></ArticleIdList></Reference><Reference><Citation>Thepparit C, Smith DR. Serotype-specific entry of dengue virus into liver cells: identification of the 37-kilodalton/67-kilodalton high-affinity laminin receptor as a dengue virus serotype 1 receptor. J Virol. 2004;78:12647&#x2013;12656. doi: 10.1128/JVI.78.22.12647-12656.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.22.12647-12656.2004</ArticleId><ArticleId IdType="pmc">PMC525075</ArticleId><ArticleId IdType="pubmed">15507651</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes-Del Valle J, Chavez-Salinas S, Medina F, Del Angel RM. Heat shock protein 90 and heat shock protein 70 are components of dengue virus receptor complex in human cells. J Virol. 2005;79:4557&#x2013;4567. doi: 10.1128/JVI.79.8.4557-4567.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.8.4557-4567.2005</ArticleId><ArticleId IdType="pmc">PMC1069525</ArticleId><ArticleId IdType="pubmed">15795242</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller JL, de Wet BJ, Martinez-Pomares L, Radcliffe CM, Dwek RA, Rudd PM, Gordon S. The mannose receptor mediates dengue virus infection of macrophages. PLoS pathogens. 2008;4:e17. doi: 10.1371/journal.ppat.0040017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.0040017</ArticleId><ArticleId IdType="pmc">PMC2233670</ArticleId><ArticleId IdType="pubmed">18266465</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen ST, Lin YL, Huang MT, Wu MF, Cheng SC, Lei HY, Lee CK, Chiou TW, Wong CH, Hsieh SL. CLEC5A is critical for dengue-virus-induced lethal disease. Nature. 2008;453:672&#x2013;676. doi: 10.1038/nature07013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature07013</ArticleId><ArticleId IdType="pubmed">18496526</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan SW, Lin CF, Lu YT, Lei HY, Anderson R, Lin YS. Endothelial cell surface expression of protein disulfide isomerase activates beta1 and beta3 integrins and facilitates dengue virus infection. J Cell Biochem. 2012;113:1681&#x2013;1691.</Citation><ArticleIdList><ArticleId IdType="pubmed">22422622</ArticleId></ArticleIdList></Reference><Reference><Citation>Falgout B, Chanock R, Lai CJ. Proper processing of dengue virus nonstructural glycoprotein NS1 requires the N-terminal hydrophobic signal sequence and the downstream nonstructural protein NS2a. J Virol. 1989;63:1852&#x2013;1860.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC250595</ArticleId><ArticleId IdType="pubmed">2522997</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanlaya R, Pattanakitsakul SN, Sinchaikul S, Chen ST, Thongboonkerd V. Vimentin interacts with heterogeneous nuclear ribonucleoproteins and dengue nonstructural protein 1 and is important for viral replication and release. Mol Biosyst. 2010;6:795&#x2013;806. doi: 10.1039/b923864f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/b923864f</ArticleId><ArticleId IdType="pubmed">20567765</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindenbach BD, Rice CM. Genetic interaction of flavivirus nonstructural proteins NS1 and NS4A as a determinant of replicase function. J Virol. 1999;73:4611&#x2013;4621.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC112502</ArticleId><ArticleId IdType="pubmed">10233920</ArticleId></ArticleIdList></Reference><Reference><Citation>Umareddy I, Chao A, Sampath A, Gu F, Vasudevan SG. Dengue virus NS4B interacts with NS3 and dissociates it from single-stranded RNA. J Gen Virol. 2006;87:2605&#x2013;2614. doi: 10.1099/vir.0.81844-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.81844-0</ArticleId><ArticleId IdType="pubmed">16894199</ArticleId></ArticleIdList></Reference><Reference><Citation>Falkler WA Jr, Diwan AR, Halstead SB. Human antibody to dengue soluble complement-fixing (SCF) antigens. J Immunol. 1973;111:1804&#x2013;1809.</Citation><ArticleIdList><ArticleId IdType="pubmed">4201557</ArticleId></ArticleIdList></Reference><Reference><Citation>Avirutnan P, Punyadee N, Noisakran S, Komoltri C, Thiemmeca S, Auethavornanan K, Jairungsri A, Kanlaya R, Tangthawornchaikul N, Puttikhunt C. et al.Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement. J Infect Dis. 2006;193:1078&#x2013;1088. doi: 10.1086/500949.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/500949</ArticleId><ArticleId IdType="pubmed">16544248</ArticleId></ArticleIdList></Reference><Reference><Citation>Avirutnan P, Hauhart RE, Somnuke P, Blom AM, Diamond MS, Atkinson JP. Binding of flavivirus nonstructural protein NS1 to C4b binding protein modulates complement activation. J Immunol. 2011;187:424&#x2013;433. doi: 10.4049/jimmunol.1100750.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1100750</ArticleId><ArticleId IdType="pmc">PMC3119735</ArticleId><ArticleId IdType="pubmed">21642539</ArticleId></ArticleIdList></Reference><Reference><Citation>Pawitan JA. Dengue virus infection: predictors for severe dengue. Acta medica Indonesiana. 2011;43:129&#x2013;135.</Citation><ArticleIdList><ArticleId IdType="pubmed">21785176</ArticleId></ArticleIdList></Reference><Reference><Citation>Benarroch D, Egloff MP, Mulard L, Guerreiro C, Romette JL, Canard B. A structural basis for the inhibition of the NS5 dengue virus mRNA 2&#x2032;-O-methyltransferase domain by ribavirin 5&#x2032;-triphosphate. J Biol Chem. 2004;279:35638&#x2013;35643. doi: 10.1074/jbc.M400460200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M400460200</ArticleId><ArticleId IdType="pubmed">15152003</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan BH, Fu J, Sugrue RJ, Yap EH, Chan YC, Tan YH. Recombinant dengue type 1 virus NS5 protein expressed in Escherichia coli exhibits RNA-dependent RNA polymerase activity. Virology. 1996;216:317&#x2013;325. doi: 10.1006/viro.1996.0067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.1996.0067</ArticleId><ArticleId IdType="pubmed">8607261</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapoor M, Zhang L, Ramachandra M, Kusukawa J, Ebner KE, Padmanabhan R. Association between NS3 and NS5 proteins of dengue virus type 2 in the putative RNA replicase is linked to differential phosphorylation of NS5. J Biol Chem. 1995;270:19100&#x2013;19106. doi: 10.1074/jbc.270.32.19100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.270.32.19100</ArticleId><ArticleId IdType="pubmed">7642575</ArticleId></ArticleIdList></Reference><Reference><Citation>Pryor MJ, Rawlinson SM, Butcher RE, Barton CL, Waterhouse TA, Vasudevan SG, Bardin PG, Wright PJ, Jans DA, Davidson AD. Nuclear localization of dengue virus nonstructural protein 5 through its importin alpha/beta-recognized nuclear localization sequences is integral to viral infection. Traffic. 2007;8:795&#x2013;807. doi: 10.1111/j.1600-0854.2007.00579.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0854.2007.00579.x</ArticleId><ArticleId IdType="pubmed">17537211</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy BR, Whitehead SS. Immune response to dengue virus and prospects for a vaccine. Annu Rev Immunol. 2011;29:587&#x2013;619. doi: 10.1146/annurev-immunol-031210-101315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-031210-101315</ArticleId><ArticleId IdType="pubmed">21219187</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmons CP, Farrar JJ, Nguyen V, Wills B. Dengue. N Engl J Med. 2012;366:1423&#x2013;1432. doi: 10.1056/NEJMra1110265.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1110265</ArticleId><ArticleId IdType="pubmed">22494122</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas SJ, Endy TP. Critical issues in dengue vaccine development. Curr Opin Infect Dis. 2011;24:442&#x2013;450. doi: 10.1097/QCO.0b013e32834a1b0b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QCO.0b013e32834a1b0b</ArticleId><ArticleId IdType="pubmed">21799408</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead SB. Controversies in dengue pathogenesis. Paediatrics inter child health. 2012;32(Suppl 1):5&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3381449</ArticleId><ArticleId IdType="pubmed">22668442</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan SW, Lin CF, Yeh TM, Liu CC, Liu HS, Wang S, Ling P, Anderson R, Lei HY, Lin YS. Autoimmunity in dengue pathogenesis. J Formosan Med Assoc = Taiwan yi zhi. 2013;112:3&#x2013;11. doi: 10.1016/j.jfma.2012.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jfma.2012.11.006</ArticleId><ArticleId IdType="pubmed">23332423</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueiredo MA, Rodrigues LC, Barreto ML, Lima JW, Costa MC, Morato V, Blanton R, Vasconcelos PF, Nunes MR, Teixeira MG. Allergies and diabetes as risk factors for dengue hemorrhagic fever: results of a case control study. PLoS Negl Trop Dis. 2010;4:e699. doi: 10.1371/journal.pntd.0000699.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0000699</ArticleId><ArticleId IdType="pmc">PMC2879373</ArticleId><ArticleId IdType="pubmed">20532230</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang J, Salim A, Lee VJ, Hibberd ML, Chia KS, Leo YS, Lye DC. Diabetes with hypertension as risk factors for adult dengue hemorrhagic fever in a predominantly dengue serotype 2 epidemic: a case control study. PLoS Negl Trop Dis. 2012;6:e1641. doi: 10.1371/journal.pntd.0001641.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0001641</ArticleId><ArticleId IdType="pmc">PMC3341340</ArticleId><ArticleId IdType="pubmed">22563519</ArticleId></ArticleIdList></Reference><Reference><Citation>Guilarde AO, Turchi MD, Siqueira JB Jr, Feres VC, Rocha B, Levi JE, Souza VA, Boas LS, Pannuti CS, Martelli CM. Dengue and dengue hemorrhagic fever among adults: clinical outcomes related to viremia, serotypes, and antibody response. J Infect Dis. 2008;197:817&#x2013;824. doi: 10.1086/528805.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/528805</ArticleId><ArticleId IdType="pubmed">18269315</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan NT, Hirayama K. Host genetic susceptibility to severe dengue infection. Tropical med health. 2011;39:73&#x2013;81. doi: 10.2149/tmh.2011-02.</Citation><ArticleIdList><ArticleId IdType="doi">10.2149/tmh.2011-02</ArticleId><ArticleId IdType="pmc">PMC3317601</ArticleId><ArticleId IdType="pubmed">22500139</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothman AL. Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nat Rev Immunol. 2011;11:532&#x2013;543. doi: 10.1038/nri3014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3014</ArticleId><ArticleId IdType="pubmed">21760609</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S, Endy TP, Raengsakulrach B, Rothman AL, Ennis FA, Nisalak A. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis. 2000;181:2&#x2013;9. doi: 10.1086/315215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/315215</ArticleId><ArticleId IdType="pubmed">10608744</ArticleId></ArticleIdList></Reference><Reference><Citation>Cologna R, Rico-Hesse R. American genotype structures decrease dengue virus output from human monocytes and dendritic cells. J Virol. 2003;77:3929&#x2013;3938. doi: 10.1128/JVI.77.7.3929-3938.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.77.7.3929-3938.2003</ArticleId><ArticleId IdType="pmc">PMC150669</ArticleId><ArticleId IdType="pubmed">12634353</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuiskunen A, Monteil V, Plumet S, Boubis L, Wahlstrom M, Duong V, Buchy P, Lundkvist A, Tolou H, Leparc-Goffart I. Phenotypic and genotypic characterization of dengue virus isolates differentiates dengue fever and dengue hemorrhagic fever from dengue shock syndrome. Arch Virol. 2011;156:2023&#x2013;2032. doi: 10.1007/s00705-011-1100-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-011-1100-2</ArticleId><ArticleId IdType="pubmed">21922323</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudiro TM, Zivny J, Ishiko H, Green S, Vaughn DW, Kalayanarooj S, Nisalak A, Norman JE, Ennis FA, Rothman AL. Analysis of plasma viral RNA levels during acute dengue virus infection using quantitative competitor reverse transcription-polymerase chain reaction. J Med Virol. 2001;63:29&#x2013;34. doi: 10.1002/1096-9071(200101)63:1&lt;29::AID-JMV1004&gt;3.0.CO;2-S.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1096-9071(200101)63:1&lt;29::AID-JMV1004&gt;3.0.CO;2-S</ArticleId><ArticleId IdType="pubmed">11130884</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang WK, Chao DY, Kao CL, Wu HC, Liu YC, Li CM, Lin SC, Ho ST, Huang JH, King CC. High levels of plasma dengue viral load during defervescence in patients with dengue hemorrhagic fever: implications for pathogenesis. Virology. 2003;305:330&#x2013;338. doi: 10.1006/viro.2002.1704.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.2002.1704</ArticleId><ArticleId IdType="pubmed">12573578</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones M, Davidson A, Hibbert L, Gruenwald P, Schlaak J, Ball S, Foster GR, Jacobs M. Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression. J Virol. 2005;79:5414&#x2013;5420. doi: 10.1128/JVI.79.9.5414-5420.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.9.5414-5420.2005</ArticleId><ArticleId IdType="pmc">PMC1082737</ArticleId><ArticleId IdType="pubmed">15827155</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzon M, Jones M, Davidson A, Chain B, Jacobs M. Dengue virus NS5 inhibits interferon-alpha signaling by blocking signal transducer and activator of transcription 2 phosphorylation. J Infect Dis. 2009;200:1261&#x2013;1270. doi: 10.1086/605847.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/605847</ArticleId><ArticleId IdType="pubmed">19754307</ArticleId></ArticleIdList></Reference><Reference><Citation>Munoz-Jordan JL, Laurent-Rolle M, Ashour J, Martinez-Sobrido L, Ashok M, Lipkin WI, Garcia-Sastre A. Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. J Virol. 2005;79:8004&#x2013;8013. doi: 10.1128/JVI.79.13.8004-8013.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.13.8004-8013.2005</ArticleId><ArticleId IdType="pmc">PMC1143737</ArticleId><ArticleId IdType="pubmed">15956546</ArticleId></ArticleIdList></Reference><Reference><Citation>Munoz-Jordan JL, Sanchez-Burgos GG, Laurent-Rolle M, Garcia-Sastre A. Inhibition of interferon signaling by dengue virus. Proc Natl Acad Sci USA. 2003;100:14333&#x2013;14338. doi: 10.1073/pnas.2335168100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2335168100</ArticleId><ArticleId IdType="pmc">PMC283592</ArticleId><ArticleId IdType="pubmed">14612562</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagni S, Fernandez-Sesma A. Evasion of the human innate immune system by dengue virus. Immunol Res. 2012;54(1-3):152&#x2013;159. doi: 10.1007/s12026-012-8334-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-012-8334-2</ArticleId><ArticleId IdType="pmc">PMC4020710</ArticleId><ArticleId IdType="pubmed">22569913</ArticleId></ArticleIdList></Reference><Reference><Citation>Green S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Suntayakorn S, Nisalak A, Lew R, Innis BL, Kurane I, Rothman AL, Ennis FA. Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J Infect Dis. 1999;179:755&#x2013;762. doi: 10.1086/314680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/314680</ArticleId><ArticleId IdType="pubmed">10068569</ArticleId></ArticleIdList></Reference><Reference><Citation>Green S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Suntayakorn S, Nisalak A, Rothman AL, Ennis FA. Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity. J Med Virol. 1999;59:329&#x2013;334. doi: 10.1002/(SICI)1096-9071(199911)59:3&lt;329::AID-JMV12&gt;3.0.CO;2-G.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1096-9071(199911)59:3&lt;329::AID-JMV12&gt;3.0.CO;2-G</ArticleId><ArticleId IdType="pubmed">10502265</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang YH, Lei HY, Liu HS, Lin YS, Liu CC, Yeh TM. Dengue virus infects human endothelial cells and induces IL-6 and IL-8 production. Am J Trop Med Hyg. 2000;63:71&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">11357999</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurane I, Innis BL, Nimmannitya S, Nisalak A, Meager A, Ennis FA. High levels of interferon alpha in the sera of children with dengue virus infection. Am J Trop Med Hyg. 1993;48:222&#x2013;229.</Citation><ArticleIdList><ArticleId IdType="pubmed">8447527</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurane I, Innis BL, Nimmannitya S, Nisalak A, Meager A, Janus J, Ennis FA. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. J Clin Invest. 1991;88:1473&#x2013;1480. doi: 10.1172/JCI115457.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI115457</ArticleId><ArticleId IdType="pmc">PMC295652</ArticleId><ArticleId IdType="pubmed">1939640</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurane I, Janus J, Ennis FA. Dengue virus infection of human skin fibroblasts in vitro production of IFN-beta, IL-6 and GM-CSF. Arch Virol. 1992;124:21&#x2013;30. doi: 10.1007/BF01314622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01314622</ArticleId><ArticleId IdType="pubmed">1571018</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead SB, Mahalingam S, Marovich MA, Ubol S, Mosser DM. Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes. Lancet Infect Dis. 2010;10:712&#x2013;722. doi: 10.1016/S1473-3099(10)70166-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70166-3</ArticleId><ArticleId IdType="pmc">PMC3057165</ArticleId><ArticleId IdType="pubmed">20883967</ArticleId></ArticleIdList></Reference><Reference><Citation>Srikiatkhachorn A, Green S. Markers of dengue disease severity. Curr Top Microbiol Immunol. 2010;338:67&#x2013;82. doi: 10.1007/978-3-642-02215-9_6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-642-02215-9_6</ArticleId><ArticleId IdType="pubmed">19802579</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin CF, Lei HY, Liu CC, Liu HS, Yeh TM, Wang ST, Yang TI, Sheu FC, Kuo CF, Lin YS. Generation of IgM anti-platelet autoantibody in dengue patients. J Med Virol. 2001;63:143&#x2013;149. doi: 10.1002/1096-9071(20000201)63:2&lt;143::AID-JMV1009&gt;3.0.CO;2-L.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1096-9071(20000201)63:2&lt;143::AID-JMV1009&gt;3.0.CO;2-L</ArticleId><ArticleId IdType="pubmed">11170051</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin CF, Lei HY, Shiau AL, Liu CC, Liu HS, Yeh TM, Chen SH, Lin YS. Antibodies from dengue patient sera cross-react with endothelial cells and induce damage. J Med Virol. 2003;69:82&#x2013;90. doi: 10.1002/jmv.10261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.10261</ArticleId><ArticleId IdType="pubmed">12436482</ArticleId></ArticleIdList></Reference><Reference><Citation>Green S, Rothman A. Immunopathological mechanisms in dengue and dengue hemorrhagic fever. Curr Opin Infect Dis. 2006;19:429&#x2013;436. doi: 10.1097/01.qco.0000244047.31135.fa.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.qco.0000244047.31135.fa</ArticleId><ArticleId IdType="pubmed">16940865</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin CF, Wan SW, Cheng HJ, Lei HY, Lin YS. Autoimmune pathogenesis in dengue virus infection. Viral immunology. 2006;19:127&#x2013;132. doi: 10.1089/vim.2006.19.127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vim.2006.19.127</ArticleId><ArticleId IdType="pubmed">16817755</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YS, Yeh TM, Lin CF, Wan SW, Chuang YC, Hsu TK, Liu HS, Liu CC, Anderson R, Lei HY. Molecular mimicry between virus and host and its implications for dengue disease pathogenesis. Exp Biol Med (Maywood) 2011;236:515&#x2013;523. doi: 10.1258/ebm.2011.010339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1258/ebm.2011.010339</ArticleId><ArticleId IdType="pubmed">21502191</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang T, Cardosa MJ, Guzman MG. Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF/DSS) Immunol Cell Biol. 2007;85:43&#x2013;45. doi: 10.1038/sj.icb.7100008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.icb.7100008</ArticleId><ArticleId IdType="pubmed">17130899</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen MC, Lin CF, Lei HY, Lin SC, Liu HS, Yeh TM, Anderson R, Lin YS. Deletion of the C-terminal region of dengue virus nonstructural protein 1 (NS1) abolishes anti-NS1-mediated platelet dysfunction and bleeding tendency. J Immunol. 2009;183:1797&#x2013;1803. doi: 10.4049/jimmunol.0800672.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0800672</ArticleId><ArticleId IdType="pubmed">19592650</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang YH, Chang BI, Lei HY, Liu HS, Liu CC, Wu HL, Yeh TM. Antibodies against dengue virus E protein peptide bind to human plasminogen and inhibit plasmin activity. Clin Exp Immunol. 1997;110:35&#x2013;40. doi: 10.1111/j.1365-2249.1997.499-ce1398.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2249.1997.499-ce1398.x</ArticleId><ArticleId IdType="pmc">PMC1904795</ArticleId><ArticleId IdType="pubmed">9353146</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang KJ, Yang YC, Lin YS, Huang JH, Liu HS, Yeh TM, Chen SH, Liu CC, Lei HY. The dual-specific binding of dengue virus and target cells for the antibody-dependent enhancement of dengue virus infection. J Immunol. 2006;176:2825&#x2013;2832.</Citation><ArticleIdList><ArticleId IdType="pubmed">16493039</ArticleId></ArticleIdList></Reference><Reference><Citation>Boonnak K, Slike BM, Burgess TH, Mason RM, Wu SJ, Sun P, Porter K, Rudiman IF, Yuwono D, Puthavathana P, Marovich MA. Role of dendritic cells in antibody-dependent enhancement of dengue virus infection. J Virol. 2008;82:3939&#x2013;3951. doi: 10.1128/JVI.02484-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02484-07</ArticleId><ArticleId IdType="pmc">PMC2292981</ArticleId><ArticleId IdType="pubmed">18272578</ArticleId></ArticleIdList></Reference><Reference><Citation>Goncalvez AP, Engle RE, St Claire M, Purcell RH, Lai CJ. Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention. Proc Nat Acad Sci United States Am. 2007;104:9422&#x2013;9427. doi: 10.1073/pnas.0703498104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0703498104</ArticleId><ArticleId IdType="pmc">PMC1868655</ArticleId><ArticleId IdType="pubmed">17517625</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead SB. Neutralization and antibody-dependent enhancement of dengue viruses. Adv virus res. 2003;60:421&#x2013;467.</Citation><ArticleIdList><ArticleId IdType="pubmed">14689700</ArticleId></ArticleIdList></Reference><Reference><Citation>Ubol S, Phuklia W, Kalayanarooj S, Modhiran N. Mechanisms of immune evasion induced by a complex of dengue virus and preexisting enhancing antibodies. J Infect Dis. 2010;201:923&#x2013;935. doi: 10.1086/651018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/651018</ArticleId><ArticleId IdType="pubmed">20158392</ArticleId></ArticleIdList></Reference><Reference><Citation>Chareonsirisuthigul T, Kalayanarooj S, Ubol S. Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells. J Gen Virol. 2007;88:365&#x2013;375. doi: 10.1099/vir.0.82537-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.82537-0</ArticleId><ArticleId IdType="pubmed">17251552</ArticleId></ArticleIdList></Reference><Reference><Citation>Couper KN, Blount DG, Riley EM. IL-10: the master regulator of immunity to infection. J Immunol. 2008;180:5771&#x2013;5777.</Citation><ArticleIdList><ArticleId IdType="pubmed">18424693</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson EB, Brooks DG. The role of IL-10 in regulating immunity to persistent viral infections. Curr Top Microbiol Immunol. 2011;350:39&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3492216</ArticleId><ArticleId IdType="pubmed">20703965</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J exper med. 1989;170:2081&#x2013;2095. doi: 10.1084/jem.170.6.2081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.170.6.2081</ArticleId><ArticleId IdType="pmc">PMC2189521</ArticleId><ArticleId IdType="pubmed">2531194</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung M, Sabat R, Kratzschmar J, Seidel H, Wolk K, Schonbein C, Schutt S, Friedrich M, Docke WD, Asadullah K. et al.Expression profiling of IL-10-regulated genes in human monocytes and peripheral blood mononuclear cells from psoriatic patients during IL-10 therapy. Eur J Immunol. 2004;34:481&#x2013;493. doi: 10.1002/eji.200324323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.200324323</ArticleId><ArticleId IdType="pubmed">14768053</ArticleId></ArticleIdList></Reference><Reference><Citation>Fickenscher H, Hor S, Kupers H, Knappe A, Wittmann S, Sticht H. The interleukin-10 family of cytokines. Trends in immunology. 2002;23:89&#x2013;96. doi: 10.1016/S1471-4906(01)02149-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1471-4906(01)02149-4</ArticleId><ArticleId IdType="pubmed">11929132</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotenko SV. The family of IL-10-related cytokines and their receptors: related, but to what extent? Cytokine growth factor rev. 2002;13:223&#x2013;240. doi: 10.1016/S1359-6101(02)00012-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1359-6101(02)00012-6</ArticleId><ArticleId IdType="pubmed">12486876</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon SI, Logsdon NJ, Sheikh F, Donnelly RP, Walter MR. Conformational changes mediate interleukin-10 receptor 2 (IL-10R2) binding to IL-10 and assembly of the signaling complex. J Biol Chem. 2006;281:35088&#x2013;35096. doi: 10.1074/jbc.M606791200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M606791200</ArticleId><ArticleId IdType="pubmed">16982608</ArticleId></ArticleIdList></Reference><Reference><Citation>Finbloom DS, Winestock KD. IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes. J Immunol. 1995;155:1079&#x2013;1090.</Citation><ArticleIdList><ArticleId IdType="pubmed">7543512</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber-Nordt RM, Riley JK, Greenlund AC, Moore KW, Darnell JE, Schreiber RD. Stat3 recruitment by two distinct ligand-induced, tyrosine-phosphorylated docking sites in the interleukin-10 receptor intracellular domain. J Biol Chem. 1996;271:27954&#x2013;27961. doi: 10.1074/jbc.271.44.27954.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.271.44.27954</ArticleId><ArticleId IdType="pubmed">8910398</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabat R, Grutz G, Warszawska K, Kirsch S, Witte E, Wolk K, Geginat J. Biology of interleukin-10. Cytokine growth factor rev. 2010;21:331&#x2013;344. doi: 10.1016/j.cytogfr.2010.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2010.09.002</ArticleId><ArticleId IdType="pubmed">21115385</ArticleId></ArticleIdList></Reference><Reference><Citation>Duell BL, Tan CK, Carey AJ, Wu F, Cripps AW, Ulett GC. Recent insights into microbial triggers of interleukin-10 production in the host and the impact on infectious disease pathogenesis. FEMS Immunol Med Microbiol. 2012;64:295&#x2013;313. doi: 10.1111/j.1574-695X.2012.00931.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-695X.2012.00931.x</ArticleId><ArticleId IdType="pubmed">22268692</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng YL, Wang CY, Huang WC, Tsai CC, Chen CL, Shen CF, Chi CY, Lin CF. Staphylococcus aureus induces microglial inflammation via a glycogen synthase kinase 3beta-regulated pathway. Infect Immun. 2009;77:4002&#x2013;4008. doi: 10.1128/IAI.00176-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/IAI.00176-09</ArticleId><ArticleId IdType="pmc">PMC2738015</ArticleId><ArticleId IdType="pubmed">19596777</ArticleId></ArticleIdList></Reference><Reference><Citation>Gee K, Angel JB, Mishra S, Blahoianu MA, Kumar A. IL-10 regulation by HIV-Tat in primary human monocytic cells: involvement of calmodulin/calmodulin-dependent protein kinase-activated p38 MAPK and Sp-1 and CREB-1 transcription factors. J Immunol. 2007;178:798&#x2013;807.</Citation><ArticleIdList><ArticleId IdType="pubmed">17202341</ArticleId></ArticleIdList></Reference><Reference><Citation>Noh KT, Son KH, Jung ID, Kang HK, Hwang SA, Lee WS, You JC, Park YM. Protein kinase C delta (PKCdelta)-extracellular signal-regulated kinase 1/2 (ERK1/2) signaling cascade regulates glycogen synthase kinase-3 (GSK-3) inhibition-mediated interleukin-10 (IL-10) expression in lipopolysaccharide (LPS)-induced endotoxemia. J Biol Chem. 2012;287:14226&#x2013;14233. doi: 10.1074/jbc.M111.308841.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.308841</ArticleId><ArticleId IdType="pmc">PMC3340148</ArticleId><ArticleId IdType="pubmed">22393041</ArticleId></ArticleIdList></Reference><Reference><Citation>Azeredo EL, Zagne SM, Santiago MA, Gouvea AS, Santana AA, Neves-Souza PC, Nogueira RM, Miagostovich MP, Kubelka CF. Characterisation of lymphocyte response and cytokine patterns in patients with dengue fever. Immunobiology. 2001;204:494&#x2013;507. doi: 10.1078/0171-2985-00058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1078/0171-2985-00058</ArticleId><ArticleId IdType="pubmed">11776403</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen LC, Lei HY, Liu CC, Shiesh SC, Chen SH, Liu HS, Lin YS, Wang ST, Shyu HW, Yeh TM. Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients. Am J Trop Med Hyg. 2006;74:142&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pubmed">16407359</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen RF, Liu JW, Yeh WT, Wang L, Chang JC, Yu HR, Cheng JT, Yang KD. Altered T helper 1 reaction but not increase of virus load in patients with dengue hemorrhagic fever. FEMS Immunol Med Microbiol. 2005;44:43&#x2013;50. doi: 10.1016/j.femsim.2004.11.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.femsim.2004.11.012</ArticleId><ArticleId IdType="pubmed">15780577</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerrero CD, Arrieta AF, Ramirez ND, Rodriguez LS, Vega R, Bosch I, Rodriguez JA, Narvaez CF, Salgado DM. High plasma levels of soluble ST2 but not its ligand IL-33 is associated with severe forms of pediatric dengue. Cytokine. 2013;61:766&#x2013;771. doi: 10.1016/j.cyto.2012.12.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2012.12.024</ArticleId><ArticleId IdType="pubmed">23357301</ArticleId></ArticleIdList></Reference><Reference><Citation>Houghton-Trivino N, Salgado DM, Rodriguez JA, Bosch I, Castellanos JE. Levels of soluble ST2 in serum associated with severity of dengue due to tumour necrosis factor alpha stimulation. J Gen Virol. 2010;91:697&#x2013;706. doi: 10.1099/vir.0.012971-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.012971-0</ArticleId><ArticleId IdType="pubmed">19889931</ArticleId></ArticleIdList></Reference><Reference><Citation>Libraty DH, Endy TP, Houng HS, Green S, Kalayanarooj S, Suntayakorn S, Chansiriwongs W, Vaughn DW, Nisalak A, Ennis FA, Rothman AL. Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J Infect Dis. 2002;185:1213&#x2013;1221. doi: 10.1086/340365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/340365</ArticleId><ArticleId IdType="pubmed">12001037</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen TH, Lei HY, Nguyen TL, Lin YS, Huang KJ, Le BL, Lin CF, Yeh TM, Do QH, Vu TQ. et al.Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles. J Infect Dis. 2004;189:221&#x2013;232. doi: 10.1086/380762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/380762</ArticleId><ArticleId IdType="pubmed">14722886</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez AB, Garcia G, Sierra B, Alvarez M, Vazquez S, Cabrera MV, Rodriguez R, Rosario D, Martinez E, Denny T, Guzman MG. IL-10 levels in Dengue patients: some findings from the exceptional epidemiological conditions in Cuba. J Med Virol. 2004;73:230&#x2013;234. doi: 10.1002/jmv.20080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.20080</ArticleId><ArticleId IdType="pubmed">15122797</ArticleId></ArticleIdList></Reference><Reference><Citation>Butthep P, Chunhakan S, Yoksan S, Tangnararatchakit K, Chuansumrit A. Alteration of cytokines and chemokines during febrile episodes associated with endothelial cell damage and plasma leakage in dengue hemorrhagic fever. Pediatr Infect Dis J. 2012;31(12):e232&#x2013;e238. doi: 10.1097/INF.0b013e31826fd456.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0b013e31826fd456</ArticleId><ArticleId IdType="pubmed">22926216</ArticleId></ArticleIdList></Reference><Reference><Citation>Brasier AR, Ju H, Garcia J, Spratt HM, Victor SS, Forshey BM, Halsey ES, Comach G, Sierra G, Blair PJ. et al.A three-component biomarker panel for prediction of dengue hemorrhagic fever. Am J Trop Med Hyg. 2012;86:341&#x2013;348. doi: 10.4269/ajtmh.2012.11-0469.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.2012.11-0469</ArticleId><ArticleId IdType="pmc">PMC3269290</ArticleId><ArticleId IdType="pubmed">22302872</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Y, Kou Z, Zhang F, Yao X, Liu S, Ma J, Zhou Y, Zhao W, Tang X, Jin X. Both viremia and cytokine levels associate with the lack of severe disease in secondary dengue 1 infection among adult Chinese patients. PLoS One. 2010;5:e15631. doi: 10.1371/journal.pone.0015631.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0015631</ArticleId><ArticleId IdType="pmc">PMC3012067</ArticleId><ArticleId IdType="pubmed">21206915</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh WT, Chen RF, Wang L, Liu JW, Shaio MF, Yang KD. Implications of previous subclinical dengue infection but not virus load in dengue hemorrhagic fever. FEMS Immunol Med Microbiol. 2006;48:84&#x2013;90. doi: 10.1111/j.1574-695X.2006.00127.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-695X.2006.00127.x</ArticleId><ArticleId IdType="pubmed">16965355</ArticleId></ArticleIdList></Reference><Reference><Citation>Luhn K, Simmons CP, Moran E, Dung NT, Chau TN, Quyen NT, le Thao TT, Van Ngoc T, Dung NM, Wills B. et al.Increased frequencies of CD4+ CD25(high) regulatory T cells in acute dengue infection. J exper med. 2007;204:979&#x2013;985. doi: 10.1084/jem.20061381.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20061381</ArticleId><ArticleId IdType="pmc">PMC2118571</ArticleId><ArticleId IdType="pubmed">17452519</ArticleId></ArticleIdList></Reference><Reference><Citation>Boonnak K, Dambach KM, Donofrio GC, Tassaneetrithep B, Marovich MA. Cell type specificity and host genetic polymorphisms influence antibody-dependent enhancement of dengue virus infection. J Virol. 2011;85:1671&#x2013;1683. doi: 10.1128/JVI.00220-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00220-10</ArticleId><ArticleId IdType="pmc">PMC3028884</ArticleId><ArticleId IdType="pubmed">21123382</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosser DM, Zhang X. Interleukin-10: new perspectives on an old cytokine. Immunol Rev. 2008;226:205&#x2013;218. doi: 10.1111/j.1600-065X.2008.00706.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-065X.2008.00706.x</ArticleId><ArticleId IdType="pmc">PMC2724982</ArticleId><ArticleId IdType="pubmed">19161426</ArticleId></ArticleIdList></Reference><Reference><Citation>Saraiva M, O&#x2019;Garra A. The regulation of IL-10 production by immune cells. Nat Rev Immunol. 2010;10:170&#x2013;181. doi: 10.1038/nri2711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2711</ArticleId><ArticleId IdType="pubmed">20154735</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin M, Rehani K, Jope RS, Michalek SM. Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat Immunol. 2005;6:777&#x2013;784.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1933525</ArticleId><ArticleId IdType="pubmed">16007092</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodgett JR, Ohashi PS. GSK3: an in-Toll-erant protein kinase? Nat Immunol. 2005;6:751&#x2013;752.</Citation><ArticleIdList><ArticleId IdType="pubmed">16034428</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang WC, Lin YS, Chen CL, Wang CY, Chiu WH, Lin CF. Glycogen synthase kinase-3beta mediates endoplasmic reticulum stress-induced lysosomal apoptosis in leukemia. J Pharmacol Exp Ther. 2009;329:524&#x2013;531. doi: 10.1124/jpet.108.148122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.108.148122</ArticleId><ArticleId IdType="pubmed">19188482</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu X, Paik PK, Chen J, Yarilina A, Kockeritz L, Lu TT, Woodgett JR, Ivashkiv LB. IFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins. Immunity. 2006;24:563&#x2013;574. doi: 10.1016/j.immuni.2006.02.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2006.02.014</ArticleId><ArticleId IdType="pubmed">16713974</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin CF, Tsai CC, Huang WC, Wang CY, Tseng HC, Wang Y, Kai JI, Wang SW, Cheng YL. IFN-gamma synergizes with LPS to induce nitric oxide biosynthesis through glycogen synthase kinase-3-inhibited IL-10. J Cell Biochem. 2008;105:746&#x2013;755. doi: 10.1002/jcb.21868.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.21868</ArticleId><ArticleId IdType="pubmed">18655171</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayr B, Montminy M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol. 2001;2:599&#x2013;609. doi: 10.1038/35085068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35085068</ArticleId><ArticleId IdType="pubmed">11483993</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu CT, Chuang DM. Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders. Pharmacol Ther. 2010;128:281&#x2013;304. doi: 10.1016/j.pharmthera.2010.07.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2010.07.006</ArticleId><ArticleId IdType="pmc">PMC3167234</ArticleId><ArticleId IdType="pubmed">20705090</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiol CJ, Williams JS, Chou CH, Wang QM, Roach PJ, Andrisani OM. A secondary phosphorylation of CREB341 at Ser129 is required for the cAMP-mediated control of gene expression. A role for glycogen synthase kinase-3 in the control of gene expression. J Biol Chem. 1994;269:32187&#x2013;32193.</Citation><ArticleIdList><ArticleId IdType="pubmed">7798217</ArticleId></ArticleIdList></Reference><Reference><Citation>Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature. 1995;378:785&#x2013;789. doi: 10.1038/378785a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/378785a0</ArticleId><ArticleId IdType="pubmed">8524413</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang X, Yu SX, Lu Y, Bast RC Jr, Woodgett JR, Mills GB. Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A. Proc Natl Acad Sci U S A. 2000;97:11960&#x2013;11965. doi: 10.1073/pnas.220413597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.220413597</ArticleId><ArticleId IdType="pmc">PMC17277</ArticleId><ArticleId IdType="pubmed">11035810</ArticleId></ArticleIdList></Reference><Reference><Citation>Nandan D, Camargo De Oliveira C, Moeenrezakhanlou A, Lopez M, Silverman JM, Subek J, Reiner NE. Myeloid cell IL-10 production in response to leishmania involves inactivation of glycogen synthase kinase-3beta downstream of phosphatidylinositol-3 kinase. J Immunol. 2012;188:367&#x2013;378. doi: 10.4049/jimmunol.1100076.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1100076</ArticleId><ArticleId IdType="pubmed">22140263</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambert SL, Martinez OM. Latent membrane protein 1 of EBV activates phosphatidylinositol 3-kinase to induce production of IL-10. J Immunol. 2007;179:8225&#x2013;8234.</Citation><ArticleIdList><ArticleId IdType="pubmed">18056366</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostrowski MA, Gu JX, Kovacs C, Freedman J, Luscher MA, MacDonald KS. Quantitative and qualitative assessment of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cell immunity to gag in HIV-1-infected individuals with differential disease progression: reciprocal interferon-gamma and interleukin-10 responses. J Infect Dis. 2001;184:1268&#x2013;1278. doi: 10.1086/324005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/324005</ArticleId><ArticleId IdType="pubmed">11679915</ArticleId></ArticleIdList></Reference><Reference><Citation>Woitas RP, Petersen U, Moshage D, Brackmann HH, Matz B, Sauerbruch T, Spengler U. HCV-specific cytokine induction in monocytes of patients with different outcomes of hepatitis C. World j gastroenterol WJG. 2002;8:562&#x2013;566.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4656444</ArticleId><ArticleId IdType="pubmed">12046093</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshimura A, Naka T, Kubo M. SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol. 2007;7:454&#x2013;465. doi: 10.1038/nri2093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2093</ArticleId><ArticleId IdType="pubmed">17525754</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang J, Kunkel SL, Chang CH. Negative regulation of MyD88-dependent signaling by IL-10 in dendritic cells. Proc Natl Acad Sci USA. 2009;106:18327&#x2013;18332. doi: 10.1073/pnas.0905815106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0905815106</ArticleId><ArticleId IdType="pmc">PMC2775313</ArticleId><ArticleId IdType="pubmed">19815506</ArticleId></ArticleIdList></Reference><Reference><Citation>El Kasmi KC, Holst J, Coffre M, Mielke L, de Pauw A, Lhocine N, Smith AM, Rutschman R, Kaushal D, Shen Y. et al.General nature of the STAT3-activated anti-inflammatory response. J Immunol. 2006;177:7880&#x2013;7888.</Citation><ArticleIdList><ArticleId IdType="pubmed">17114459</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore KW, de Waal MR, Coffman RL, O&#x2019;Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001;19:683&#x2013;765. doi: 10.1146/annurev.immunol.19.1.683.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.immunol.19.1.683</ArticleId><ArticleId IdType="pubmed">11244051</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray PJ. STAT3-mediated anti-inflammatory signalling. Biochem Soc Trans. 2006;34:1028&#x2013;1031.</Citation><ArticleIdList><ArticleId IdType="pubmed">17073743</ArticleId></ArticleIdList></Reference><Reference><Citation>Dagvadorj J, Naiki Y, Tumurkhuu G, Hassan F, Islam S, Koide N, Mori I, Yoshida T, Yokochi T. Interleukin-10 inhibits tumor necrosis factor-alpha production in lipopolysaccharide-stimulated RAW 264.7 cells through reduced MyD88 expression. Innate immunity. 2008;14:109&#x2013;115. doi: 10.1177/1753425908089618.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1753425908089618</ArticleId><ArticleId IdType="pubmed">18713727</ArticleId></ArticleIdList></Reference><Reference><Citation>Vicari AP, Trinchieri G. Interleukin-10 in viral diseases and cancer: exiting the labyrinth? Immunol Rev. 2004;202:223&#x2013;236. doi: 10.1111/j.0105-2896.2004.00216.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.0105-2896.2004.00216.x</ArticleId><ArticleId IdType="pubmed">15546396</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaturvedi UC, Agarwal R, Elbishbishi EA, Mustafa AS. Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis. FEMS Immunol Med Microbiol. 2000;28:183&#x2013;188. doi: 10.1111/j.1574-695X.2000.tb01474.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-695X.2000.tb01474.x</ArticleId><ArticleId IdType="pubmed">10865168</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackburn SD, Wherry EJ. IL-10, T cell exhaustion and viral persistence. Trends Microbiol. 2007;15:143&#x2013;146. doi: 10.1016/j.tim.2007.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2007.02.006</ArticleId><ArticleId IdType="pubmed">17336072</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks DG, Lee AM, Elsaesser H, McGavern DB, Oldstone MB. IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infection. J exper med. 2008;205:533&#x2013;541. doi: 10.1084/jem.20071948.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20071948</ArticleId><ArticleId IdType="pmc">PMC2275377</ArticleId><ArticleId IdType="pubmed">18332180</ArticleId></ArticleIdList></Reference><Reference><Citation>Endy TP, Nisalak A, Chunsuttitwat S, Vaughn DW, Green S, Ennis FA, Rothman AL, Libraty DH. Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand. J Infect Dis. 2004;189:990&#x2013;1000. doi: 10.1086/382280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/382280</ArticleId><ArticleId IdType="pubmed">14999601</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa VV, Fagundes CT, Valadao DF, Cisalpino D, Dias AC, Silveira KD, Kangussu LM, Avila TV, Bonfim MR, Bonaventura D. et al.A model of DENV-3 infection that recapitulates severe disease and highlights the importance of IFN-gamma in host resistance to infection. PLoS Negl Trop Dis. 2012;6:e1663. doi: 10.1371/journal.pntd.0001663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0001663</ArticleId><ArticleId IdType="pmc">PMC3362616</ArticleId><ArticleId IdType="pubmed">22666512</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfe DN, Karanikas AT, Hester SE, Kennett MJ, Harvill ET. IL-10 induction by Bordetella parapertussis limits a protective IFN-gamma response. J Immunol. 2010;184:1392&#x2013;1400. doi: 10.4049/jimmunol.0803045.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0803045</ArticleId><ArticleId IdType="pmc">PMC5180427</ArticleId><ArticleId IdType="pubmed">20042578</ArticleId></ArticleIdList></Reference><Reference><Citation>Groux H, Cottrez F. The complex role of interleukin-10 in autoimmunity. J Autoimmun. 2003;20:281&#x2013;285. doi: 10.1016/S0896-8411(03)00044-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-8411(03)00044-1</ArticleId><ArticleId IdType="pubmed">12791313</ArticleId></ArticleIdList></Reference><Reference><Citation>Wakkach A, Cottrez F, Groux H. Can interleukin-10 be used as a true immunoregulatory cytokine? Eur Cytokine Netw. 2000;11:153&#x2013;160.</Citation><ArticleIdList><ArticleId IdType="pubmed">10903794</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill N, Sarvetnick N. Cytokines: promoters and dampeners of autoimmunity. Curr Opin Immunol. 2002;14:791&#x2013;797. doi: 10.1016/S0952-7915(02)00403-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0952-7915(02)00403-X</ArticleId><ArticleId IdType="pubmed">12413531</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>